Editorial Commentary: Who is "Special" Now?

Affiliations

Editorial

Ashwin Balagopal et al. Clin Infect Dis. 2015.

. 2015 Sep 1;61(5):826-8.

doi: 10.1093/cid/civ382. Epub 2015 May 14.

¹ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

No abstract available

Keywords: HIV/HCV coinfection; cirrhosis; direct-acting antivirals; hepatitis C virus; interferon.

Comment on

High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.
Piroth L, Paniez H, Taburet AM, Vincent C, Rosenthal E, Lacombe K, Billaud E, Rey D, Zucman D, Bailly F, Bronowicki JP, Simony M, Diallo A, Izopet J, Aboulker JP, Meyer L, Molina JM; ANRS HC30 QUADRIH Study Group. Piroth L, et al. Clin Infect Dis. 2015 Sep 1;61(5):817-25. doi: 10.1093/cid/civ381. Epub 2015 May 14. Clin Infect Dis. 2015. PMID: 25977266 Clinical Trial.